Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: Cancer Res. 2011 Jul 1;71(16):5558–5568. doi: 10.1158/0008-5472.CAN-10-4543

Figure 3. Deletion of the STP segment in GPR56 led to significantly enhanced tumor growth and angiogenesis.

Figure 3

A. Western blot analyses of the expression of ΔSTP-GPR56 in MC-1 cells.

B. Expression of ΔSTP-GPR56 led to enhanced tumor growth. *: p < 0.05; **: p < 0.01; ***: p < 0.001. Student’s t-test.

C. Expression of ΔSTP-GPR56 led to enhanced tumor angiogenesis. Tumor sections were stained with the anti-PECAM antibody (green) and the anti-GPRC antibody (red).

D. Blood vessel density on sections stained with anti-PECAM antibody was quantified as described in the legend for Figure 2. *: p < 0.05; **: p < 0.01; ***: p < 0.001. Student’s t-test.